Abstract C149: Assessing the impact of the Affordable Care Act on reducing racial disparities in insurance rates and mortality for childhood Acute Lymphoblastic Leukemia survivors: A report from the Children's Oncology Group
Abstract
Childhood cancer remains one of the leading causes of death from disease among children Despite novel therapeutic options and improved risk stratification over the past several decades, substantial racial and ethnic disparities in outcome persist. The Patient Protection and Affordable Care Act (ACA) sought to improve health disparities by expanding Medicaid coverage to parents and their children with incomes below 138% of the federal poverty level. Despite children being among the most insured age group, there are significant disparities in insurance coverage. Because the timing of Medicaid expansion varied by state, ranging from 2010 to 2023, we examined whether these state-specific differences in expansion date impacted childhood acute lymphoblastic leukemia (ALL) insurance and mortality outcomes in a nationwide population of ALL cases. Cases of childhood and adolescent ALL patients (26 years and younger) enrolled in the Childhood Cancer Research Network (CCRN) between December 1, 2007, to December 31, 2017 and registered in nine Children Oncology Group clinical trials were included for analysis. We conducted a difference-in-differences (DiD) analysis with multiple time periods, to estimate the Average Treatment Effect on the Treated (ATT) of Medicaid expansion on childhood insurance rates and 5-year (ALL) overall survival rates f, stratified by racial/ethnic groups. Given the staggered implementation of the ACA, our DiD model had five time periods based on the calendar year of Medicaid Expansion (2010, 2011, 2014, 2015, and 2016) and two groups (treated-Medicaid Expanded and control- Medicaid not expanded). Models were adjusted for age, sex, ALL risk and state expansion type (non-expansion, 2014 expansion states, post-2014 expansion states), all of which were determined at the time of CCRN enrollment. We excluded cases residing outside of the United States, those with unknown insurance status, and those with unknown state residence. Crude DiD models and adjusted DiD models were stratified by race/ethnicity (white, black, asian, other). 10859 cases of childhood ALL were included for analysis. Across both crude and adjusted models, Medicaid expansion was not associated with significant changes in mortality among non-Hispanic White or Hispanic children. After adjusting for covariates, Medicaid expansion was associated with reduced overall ALL mortality among non-Hispanic Black children (ATT -15.5 ppt; 95% CI -30.4 to -0.7), but not with increased rates of insurance coverage. This mortality reduction exceeded the baseline Black mortality rate (8.7%). Medicaid expansion was not associated with significant changes in Medicaid coverage rates. However, it was associated with a significant reduction in all-cause mortality among non-Hispanic Black children, the subgroup with the highest baseline mortality. Given the large point estimate for non-Hispanic Black children, this finding warrants cautious interpretation and further study. Jinhee Cha, Helen M. Parsons, Logan Spector, Traci Toomey, Erin Marcotte. Assessing the impact of the Affordable Care Act on reducing racial disparities in insurance rates and mortality for childhood Acute Lymphoblastic Leukemia survivors: A report from the Children's Oncology Group [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr C149.